Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer
Saved in:
| Published in: | Cancer Management and Research |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2026
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1868847763352977408 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Cancer Management and Research |
| description | |
| discipline_display | Oncology |
| discipline_facet | Oncology |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:94980 |
| institution | FRELIP |
| journal_source_facet | Cancer Management and Research |
| last_indexed | 2026-06-24T03:35:13.062Z |
| publishDate | 2026 |
| publishDateSort | 2026 |
| record_format | rss_article |
| spellingShingle | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer Oncology General Oncology |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Oncology General Oncology |
| subject_facet | Oncology General Oncology |
| title | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_alt | La combinación del suero PVT1 exón 4A y exón 9 con el antígeno prostático específico sérico muestra potencial para mejorar la identificación y estratificación de riesgo del cáncer de próstata La combinaison du sérum PVT1 exon 4A et exon 9 avec l'antigène prostatique spécifique sérique montre un potentiel pour améliorer l'identification et la stratification du risque du cancer de la prostate A Combinação do PVT1 Soro Éxon 4A e Éxon 9 com o Antígeno Prostático Específico Soro Mostra Potencial para Melhorar a Identificação e Estratificação de Risco do Câncer de Próstata |
| title_auth | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_es_txt | La combinación del suero PVT1 exón 4A y exón 9 con el antígeno prostático específico sérico muestra potencial para mejorar la identificación y estratificación de riesgo del cáncer de próstata |
| title_fr_txt | La combinaison du sérum PVT1 exon 4A et exon 9 avec l'antigène prostatique spécifique sérique montre un potentiel pour améliorer l'identification et la stratification du risque du cancer de la prostate |
| title_full | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_fullStr | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_full_unstemmed | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_pt_txt | A Combinação do PVT1 Soro Éxon 4A e Éxon 9 com o Antígeno Prostático Específico Soro Mostra Potencial para Melhorar a Identificação e Estratificação de Risco do Câncer de Próstata |
| title_short | Combining Serum PVT1 Exon 4A and Exon 9 with Serum Prostate-Specific Antigen Shows Potential for Improving Identification and Risk Stratification of Prostate Cancer |
| title_sort | combining serum pvt1 exon 4a and exon 9 with serum prostate-specific antigen shows potential for improving identification and risk stratification of prostate cancer |
| topic | Oncology General Oncology |
| url | https://www.dovepress.com/combining-serum-pvt1-exon-4a-and-exon-9-with-serum-prostate-specific-a-peer-reviewed-fulltext-article-CMAR |